MedTrace Logo

Watermelon/UBIQuinone Study

NCT04972552 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-07-14

No results posted yet for this study

Summary

The objective of the proposed pilot trial is to determine the feasibility and safety of increasing watermelon consumption, with or without coenzyme Q supplementation in patients after kidney transplantation on kidney function and urinary protein excretion.

Conditions

  • Kidney Transplantation

Interventions

DIETARY_SUPPLEMENT

coenzyme Q10

Participants will take 800-1200 mg of coenzyme Q10 capsule per day

OTHER

Watermelon diet

Participants will be asked to eat watermelon at a minimum of one meal per day 3-5 days a week

OTHER

Usual Diet

Participants will be asked to eat a usual diet but not eat any watermelon as part of their usual diet

OTHER

Placebo

Participants will be asked to take 800-1200 mg of a placebo capsule per day

Sponsors & Collaborators

Principal Investigators

  • Elaine Ku · University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2025-12-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04972552 on ClinicalTrials.gov